One of the more significant issues that taxpayers and tax practitioners have faced in recent months is the Tax Cuts and Jobs Act’s (TCJA) amendment to Section 174, requiring capitalization of ...
GlobalData on MSN
AI can reduce R&D costs to alleviate looming patent cliff pressures
Speaking at CDMI Europe 2025, GlobalData pharma analyst George El-Helou says the use of AI in R&D could help mitigate patent ...
The Inflation Reduction Act (IRA) of 2022 Section 1193 states that when engaging in drug price negotiation, the Secretary of Health and Human Services should consider, among multiple factors, ...
The U.S. Capitol in Washington, DC. A bipartisan group of lawmakers has reintroduced legislation to allow immediate expensing of research and development costs, all the way back to 2022 when the tax ...
Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...
Two recent studies aimed to quantify how much R&D costs impact a drug’s price, and how much a drug’s effectiveness correlates with its price — factors that might, in theory, help justify a sizable ...
Keysight Technologies reported notable sales growth for its fiscal third quarter, partly helped by customer interest in artificial intelligence (AI). But higher costs from newly escalated tariffs and ...
DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical R&D Outsourcing Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Pharmaceutical R&D Outsourcing Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback